Nephros (NEPH) Change in Account Payables (2014 - 2026)
Nephros' (NEPH) quarterly Change in Account Payables came in at $562000.0 in Q1 2026, up 635.24% year-on-year from $76437.8 in Q1 2025, and up 2037.93% quarter-over-quarter from -$29000.0 in Q4 2025.
Nephros (NEPH) Change in Account Payables (2014 - 2026) Analysis & Trends
Nephros' Change in Account Payables history runs 13 years deep, the most recent figure standing at $562000.0 for Q1 2026.
- On a quarterly basis, Change in Account Payables rose 635.24% year-over-year to $562000.0 in Q1 2026; TTM through Mar 2026 was $926000.0, a 262.74% increase from a year earlier, with the FY2025 full-year figure at $259000.0, up 217.73% from the prior year.
- Change in Account Payables grew to $562000.0 in Q1 2026 per NEPH's latest filing, from -$29000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $562000.0 in Q1 2026 and bottomed at -$766000.0 in Q3 2024.
- The 5-year median for Change in Account Payables is $45000.0 (2024), against an average of $8294.1.
- Across the five-year window, Change in Account Payables tumbled 675.0% in 2022 and jumped 1261.9% in 2024, its largest moves.
- Year by year, Change in Account Payables stood at -$38000.0 in 2022, then soared by 278.95% to $68000.0 in 2023, then soared by 277.94% to $257000.0 in 2024, then sank by 111.28% to -$29000.0 in 2025, then jumped by 2037.93% to $562000.0 in 2026.
- Per Business Quant, the three latest NEPH Change in Account Payables figures stand at $562000.0 (Q1 2026), -$29000.0 (Q4 2025), and $312000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -52.50 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 6.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -100.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 4.93 Mn |
| 10 | Nephros | 40.88 Mn | 36.86 Mn | 2.99 Mn | 562,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 562,000.00 |
| Mar 31, 2026 | 562,000.00 |
| Dec 31, 2025 | -29,000.00 |
| Dec 31, 2025 | -29,000.00 |
| Sep 30, 2025 | 312,000.00 |
| Sep 30, 2025 | 312,000.00 |
| Jun 30, 2025 | 81,000.00 |
| Jun 30, 2025 | 81,000.00 |
| Mar 31, 2025 | -105,000.00 |
| Mar 31, 2025 | -105,000.00 |
| Dec 31, 2024 | 257,000.00 |
| Dec 31, 2024 | 257,000.00 |
| Sep 30, 2024 | -766,000.00 |
| Sep 30, 2024 | -766,000.00 |
| Jun 30, 2024 | 45,000.00 |
| Jun 30, 2024 | 45,000.00 |
| Mar 31, 2024 | 244,000.00 |
| Mar 31, 2024 | 244,000.00 |
| Dec 31, 2023 | 68,000.00 |
| Dec 31, 2023 | 68,000.00 |